文献速递呼吸道感染

长期肺炎死亡指数:社区获得性肺炎患者国际多中心推导与验证研究

The Long-term Pneumonia Mortality Index: an international multicenter derivation and validation study for patients with community-acquired pneumonia
RSS 订阅 · PubMed 顶刊 · 肺炎 · 2026-02-25

该研究基于西班牙多中心前瞻性CAP队列推导长期肺炎死亡指数(L-PMI),并在德国、美国CAP队列及西班牙COVID-19肺炎队列中外部验证。L-PMI纳入年龄、吸烟史、养老院居住、Charlson合并症指数、CURB-65评分、无创或有创机械通气使用及院内心血管事件,推导队列AUC为0.82,验证队列AUC范围为0.75至0.88,可将患者分为低、中、高死亡风险组。

要点

  • L-PMI用于预测CAP患者出院后1年内死亡风险,推导队列AUC为0.82。
  • 外部验证AUC在CAPNETZ为0.78,美国队列为0.75,COVID-19队列为0.88。
  • L-PMI可将患者分为低、中、高死亡风险三组以辅助临床分层。

核心结论

  • L-PMI是一种新型临床预测评分,可识别出院后1年内存在死亡风险的肺炎患者。

研究设计与样本

  • L-PMI推导使用西班牙多中心前瞻性CAP研究数据,随访1年,采用逻辑回归模型预测1年死亡风险,并以AUC评估模型性能。
  • 模型在德国和美国两个独立多中心CAP队列及一个西班牙COVID-19肺炎队列中进行外部验证。
  • 从模型推导出评分以简化应用。

主要发现

  • 出院后长期死亡率在推导队列为6.3%,CAPNETZ队列为4.4%(仅随访6个月),美国队列为17.4%,COVID-19队列为3.6%。
  • L-PMI包含年龄、吸烟史、养老院居住、Charlson合并症指数评分、CURB-65评分、使用无创或有创机械通气及院内心血管事件。
  • 推导队列中L-PMI对死亡的区分度AUC为0.82(95% CI,0.78-0.85)。
  • 验证队列中AUC(95% CI)在CAPNETZ为0.78(0.73-0.83),美国队列为0.75(0.73-0.77),COVID-19队列为0.88(0.84-0.93)。
  • L-PMI可将患者按死亡风险分为低、中、高三个风险组。

关键数值与推荐

  • L-PMI评分包含7个预测因子:年龄、吸烟史、养老院居住、Charlson合并症指数评分、CURB-65评分、无创或有创机械通气使用、院内心血管事件。
  • 推导队列AUC为0.82(95% CI,0.78-0.85),验证队列AUC范围为0.75至0.88。
  • L-PMI将患者分为低、中、高死亡风险三组。

临床怎么用

  • 对社区获得性肺炎出院患者可使用L-PMI评估1年内死亡风险,识别高危患者并加强随访管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Am J Respir Crit Care Med . 2026 Jun 1;212(6):1305-1314. doi: 10.1093/ajrccm/aamag060. ABSTRACT RATIONALE: Long-term mortality after hospital discharge in community-acquired pneumonia (CAP) is a neglected issue. A validated, accurate score predicting mortality is needed. OBJECTIVE: To derive and validate the Long-term Pneumonia Mortality Index (L-PMI). METHODS: L-PMI derivation used data from a Spanish multicenter prospective study on CAP with a 1-year follow-up. A logistic regression model for predicting 1-year mortality risk was developed. Performance of the model was assessed by estimating the area under the receiver operating characteristic curve (AUC). The model was externally validated using 2 independent multicenter CAP cohorts from Germany and the United States (USA), and one COVID-19 pneumonia cohort from Spain. We then derived a score from the model to ease its application. MEASUREMENTS AND MAIN RESULTS: The long-term mortality rate after discharge was 6.3%, 4.4%, 17.4%, and 3.6% in the derivation, CAPNETZ (only 6 months of follow-up), USA, and COVID-19 cohorts, respectively. The L-PMI included age, smoking history, nursing home residency, Charlson Comorbidity Index score, CURB-65 score, use of noninvasive or invasive mechanical ventilation, and in-hospital cardiovascular events. The L-PMI showed high discrimination for mortality in the derivation cohort (AUC, 0.82 [95% CI, 0.78-0.85]). In the validation cohorts, the AUC (95% CI) ranged from 0.78 (0.73-0.83) to 0.75 (0.73-0.77) for the CAPNETZ and USA cohorts, respectively, and 0.88 (0.84-0.93) for the COVID-19 cohort. L-PMI allows classification of patients according to their mortality risk into low-, intermediate-, and high-risk groups. CONCLUSIONS: The L-PMI is a novel clinical prediction score that identifies pneumonia patients at risk of mortality up to 1 year after discharge. PMID: 41738235 | DOI: 10.1093/ajrccm/aamag060

来源:PubMed 顶刊 · 肺炎,查看原文。版权归原作者所有。

引用

  1. PubMed 顶刊 · 肺炎:The Long-term Pneumonia Mortality Index: an international multicenter derivation and validation study for patients with community-acquired pneumonia

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。